B Lymphocytic Leukemia Clinical Trials in Tianjin, Tianjin Municipality

CD19-targeted CAR T Cell Autotransfusion for the Treatment of Recurrent/Refractory B-cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma in Children With CD19+